In this episode, I discuss corneal disease and treatments with David Eveleth, PhD, the founder, president and CEO of Trefoil Therapeutics. Brought to you by Alcon · Welcome to another exciting episode of Eye Care insider :14 · Intro David Eveleth, PhD :47 · Eveleth’s background 1:05 · What’s the treatment landscape now for corneal diseases and where are we falling short for patients? 2:59 · The origins of Trefoil Therapeutics 7:27 · FGF-1: Is it just important in the endothelium or is it also im...
May 01, 2023•28 min•Season 1Ep. 26
In this episode, I chat with Nancy Lurker, CEO and board director, about EyePoint Pharmaceuticals and their latest treatments and trials. Brought to you by Alcon · Welcome to another exciting episode of Eye Care insider :13 · Intro Nancy Lurker :22 · Lurker’s background :58 · EyePoint Pharmaceuticals: the origin and transition 2:29 · Yutiq and long-acting drug delivery systems 6:07 · Additional indications for Yutiq 8:30 · What is the key factor in delivering this longer durability? 16:13 · Any ...
Apr 07, 2023•33 min•Season 1Ep. 25
In this episode, I discuss Samsara Vision’s SING IMT and its benefits of vision improvement for patients with AMD with Rebecca Kammer, OD, PhD . Brought to you by Alcon · Welcome to another exciting episode of Eye Care insider :14 · Intro for Rebecca Kammer, OD, PhD :27 · Dr. Kammer’s background 1:28 · Defining late-stage AMD patients and treatments available 5:11 · The SING IMT 9:46 · US Concerto Study Website – to learn more about the study 13:13 · Visual acuity and the SING IMT 13:48 · US tri...
Mar 21, 2023•28 min•Season 1Ep. 24
In this episode, I share my top five predictions for 2023 in the field of ophthalmology. Brought to you by Alcon Welcome to another exciting episode of Eye Care insider :52 My review of the top five predictions in ophthalmology 1:03 Prediction #1 – Vabysmo and anti-VEGF market 1:53 Prediction #2 – FDA approval for GA treatment 4:26 Prediction #3 – SNAPS eye shield for ocular protection 6:06 Prediction #4 – biosimilars and the ophthalmic therapeutic marketplace 10:08 Prediction #5 – retina analyt...
Jan 04, 2023•15 min•Season 1Ep. 23
In this episode, I share my thoughts about the five greatest innovations of the 21st century in the field of ophthalmology and how they have changed patient outcomes for the better. Brought to you by Alcon Welcome to another exciting episode of Eye Care insider :50 My review of the top five innovations in ophthalmology 1:02 Greatest Innovation #1 – anti-VEGF medications 2:06 Greatest Innovation #2 – intraocular lens implantation technology 3:26 Greatest Innovation #3 – electronic medical records...
Nov 21, 2022•8 min•Season 1Ep. 22
In this episode, I share my review of the hot topics from the AAO 2022 annual meeting and share my thoughts on the new data shared about drug trials and treatments. Brought to you by Alcon Welcome to another exciting episode of Eye Care insider :53 My review of the hot topics from the AAO 2022 annual meeting 2:20 Hot Topic #1 – wet AMD treatments 2:40 Hot Topic #2 – high-dose Eylea 6:20 Hot Topic #3 – geographic atrophy treatments 10:24 Thanks for listening 16:04 We’d love to hear from you! Send...
Oct 18, 2022•17 min•Season 1Ep. 21
In this episode, I share my preview of the hot topics for the upcoming AAO 2022 annual meeting, including my thoughts on ocular gene therapy and new treatments in the works. Welcome to another exciting episode of Eye Care insider :52 My preview of hot topics for the upcoming AAO 2022 annual meeting 1:04 Hot Topic #1 – new treatments for dry AMD or geographic atrophy 2:43 Hot Topic #2 – wet AMD management 5:55 Hot Topic #3 – ocular gene therapy 7:56 Hot Topic #4 – biosimilars 9:17 Thanks for list...
Sep 27, 2022•12 min•Season 1Ep. 20
In this episode, Jose O. Segura, wealth management advisor and certified business exit planner, discusses establishing objectives within financial planning and organization, how to diversify your portfolio in ever-changing markets and more. Intro :38 Welcome to another episode of Eye Care insider :52 About Jose Segura 1:03 For people that are listening for the first time, do you mind giving a brief of your background? 1:32 What are, in your opinion, some best practices in regard to financial pla...
Aug 23, 2022•24 min•Season 1Ep. 19
In this episode, Ashlie Leal, director of ophthalmology at FundamentalVR, discusses their fully immersive surgical training products, how virtual reality plays a role in training surgeons and more. Intro :38 Welcome to another episode of Eye Care insider :52 About Ashlie Leal 1:00 Give me a little bit of your background – how you got into this industry and your role at FundamentalVR? 1:33 Can you give our listeners some background about FundamentalVR as a company, and why should eye care profess...
Aug 09, 2022•21 min•Season 1Ep. 18
In this episode, Allisa Song, a medical student and the CEO and co-founder of Nanodropper, discusses the inception of the device, how it can benefit the eye care industry and more. Intro :38 Welcome to another episode of Eye Care insider :52 About Allisa Song 1:01 I want to hear your story about the history about the Nanodropper – how you came to this idea; what problem you were trying to solve; and how you got here? 2:02 What are the major advantages of your product? Why doesn’t our standard bo...
Jun 22, 2022•21 min•Season 1Ep. 18
In this episode, Arthur Benjamin, MD, discusses dry eye treatment and trends, the challenges dry eye patients and the eye care professionals treating them and more. Intro :37 Welcome to another episode of Eye Care insider :51 About Arthur Benjamin, MD 1:02 I wonder if you could talk about your training and what you currently do now? 1:39 Could you talk about what you’ve seen throughout the years and what you’ve seen in the trends in dry eye and how it has expanded in the population? 2:56 What is...
May 25, 2022•19 min•Season 1Ep. 17
In this episode, Dhruvin Patel, MCOptom, discusses the short- and long-term effects of blue light on our eyes, how the pandemic has exacerbated these effects and how his company, Ocushield, is looking to help protect eyes from blue light. Intro :01 Patel’s introduction and background :43 The science and necessity behind blue light blocking filters 5:35 Short-term effects of blue light on the eyes 7 :15 Long-term effects of blue light on the eyes 8:24 Are eye care professionals doing enough to pr...
Apr 29, 2022•24 min•Season 1Ep. 16
In this episode I share my top 5 predictions in ophthalmology for 2022, including my thoughts on the future of COVID-19 and ocular gene therapy. Welcome to another exciting episode of Eye Care insider :50 My top 5 predictions for 2022 1:16 Prediction #1 – on COVID-19 1:27 Prediction #2 – on wet AMD 2:43 Prediction #3 – on ocular gene therapy 4:05 Prediction #4 – on geographic atrophy 5:05 Prediction #5 – on ophthalmology media platforms 7:23 Thanks for listening 9:20 We’d love to hear from you! ...
Mar 21, 2022•10 min•Season 1Ep. 15
In this episode, Jennifer L. Mogan, MD, discusses her path into medicine, the importance of the credit card process and how it can be beneficial for eyecare practices. Welcome to another exciting episode of Eye Care insider :14 What led to the inception of the ‘Doctorpreneurship’ series? :29 About Mogan 2:16 The interview 2:47 Give us an idea of your background, your training and why you went to medicine? 3:12 How in the world did you get involved with credit card processing? 4:12 Can you summar...
Oct 18, 2021•17 min•Season 1Ep. 13
In this episode, Sue Washer, BS, MBA, discusses gene therapy in ophthalmology, ATGC’s clinical trial progress, as well as current and future challenges faced by both the cell therapy industry and ophthalmology. Welcome to another exciting episode of Eye Care insider :13 About Washer 1:51 Can you discuss what is gene therapy? How does it work on a basic level? 4:53 How do companies like AGTC make gene therapy work for diseases that may not affect as many people but still make it financially succe...
Sep 21, 2021•25 min•Season 1Ep. 12
In this episode, the third of a three-part series, John B. Pinto discusses some of the future megatrends expected for ophthalmic practices, challenge practices may face in the future, and more. Intro :13 What you think the megatrends are going to be over the next decade or so in the ophthalmic practices :50 What do you think is the most important topic or issue or challenge facing ophthalmic practices now and in the future? 4:46 If our listeners wanted to learn more, what’s the best way to conta...
Sep 01, 2021•12 min•Season 1Ep. 11
In this second episode of a three-part series, John B. Pinto discusses the job market for early-career professionals and new graduates, his perspective on what ophthalmologists have learned from the pandemic and the role telemedicine will play in the future of ophthalmology. Intro :14 What is the current negotiation position in the market for early-career and new graduate ophthalmic practice physicians? :41 I’d love to hear your perspective on what we have learned about our practices after a yea...
Jul 14, 2021•18 min•Season 1Ep. 10
In this episode, the first of a three-part series, John B. Pinto discusses how he got started in ophthalmic practice management, shares an historical perspective on the field, plus his advice for physicians. Intro :16 About John Pinto :54 On Pinto’s background, why he went into the ophthalmic practice management industry 1:39 Can you give listeners a historical perspective of how has ophthalmic practice management changed or evolved over the last 40 years? 7:13 What is the current state of ophth...
Jun 10, 2021•28 min•Season 1Ep. 9
In this episode, Rick Eiswirth, president and CEO of Alimera Sciences, shares the latest on the phase 4 New Day study of Iluvien, as well as his predictions for the future of ophthalmology. Intro :13 In this episode :18 About Rick Eiswirth :23 What’s your background? How did you get into the ophthalmology industry? 0:51 What are the benefits of Iluvien (fluocinolone acetonide intravitreal implant, Alimera Sciences)? Is this an ideal treatment for 2021? 3:36 How do you get retina specialists more...
Apr 12, 2021•25 min•Season 1Ep. 8
In this episode, Cathleen M. McCabe, MD, chief medical officer of Eye Health America, shares her insights and perspectives on intraocular lenses, MIGS, dry eye and more. Intro :14 In this episode :21 About Cathleen M. McCabe, MD :28 What is your favorite intraocular lens implant to use and why? 2:24 What is your favorite minimally invasive glaucoma surgery (MIGS) to use and why? 4:03 What is your favorite dry-eye treatment to use and why? 4:49 What’s your preferred technique for secondary IOLs? ...
Feb 25, 2021•18 min•Season 1Ep. 7
In this special episode, I sit down with this week’s co-host, my wife Yasmin P. Mali, MD, to discuss my top 5 predictions in ophthalmology in the new year. Stay tuned for a special announcement at the end of the show. Intro :14 In this episode :21 About Yasmin P. Mali, MD :35 Mali’s first prediction: The human spirit and innovation will triumph over the headline-dominating COVID-19 1:16 Yasmin Mali’s thoughts on the first predictions 2:58 Mali’s second prediction: The competition battle lines wi...
Dec 23, 2020•20 min•Season 1Ep. 6
In this episode, I sit down with wealth management advisor Jose Segura to discuss financial planning for medical professionals. Segura will also discuss some of the better investment strategies for eye care professionals. Intro :14 In this episode :21 About Segura :30 The interview 1:30 Who is Jose Segura? 1:45 Why the focus on medical professionals and physicians? 3:45 Where should an eye care professional start regarding financial planning? 6:15 As a financial professional, what strategies do ...
Nov 24, 2020•23 min•Season 1Ep. 5
In this episode, I sit down with Kester Nahen, PhD, as we discuss the use of artificial intelligence and telemedicine among retina specialists. Nahen will also discuss Notal Vision’s ForseeHome device for monitoring and the company’s Home OCT artificial intelligence-enable platform for monitoring AMD. Intro :14 In this episode :21 About Dr. Nahen 1:24 The interview 1:42 The background of Kester Nahen 2:00 Nahen’s thoughts on the current state of telemedicine and artificial intelligence 5:10 Will...
Nov 12, 2020•27 min•Season 1Ep. 4
In part 1 of this two-part series, I sit down with George B. Bartley, MD, who details the history of the American Board of Ophthalmology, plus everything you ever wanted to know about board certification and maintaining your certificate. Intro :14 In this episode :24 About Dr. Bartley :49 The interview 1:06 Who is Dr. Bartley? 1:09 History of the ABO and Dr. Bartley’s journey with them 3:51 What are the benefits of having board certification? 7:50 What are the initial steps to becoming board cer...
Aug 25, 2020•44 min•Season 1Ep. 3
In this interview with Joseph Nezgoda, MD, MBA, we discuss young ophthalmologists – or YOs – and the most important challenges this group faces. Nezgoda also provides his insight and advice for YOs embarking on their career. Intro :13 In this episode :15 About Dr. Nezgoda :23 The interview :54 Who is Dr. Nezgoda? 1:29 “Ah-ha” moments 4:13 What is a young ophthalmologist, or YO? 8:07 What is the most important topic or challenge currently facing YOs? 9:57 What’s the ideal path – academic, private...
Aug 25, 2020•30 min•Season 1Ep. 2
In this episode, John S. Pollack, MD, discusses how he got started with the American Society of Retina Specialists, gives the scoop on the PAT survey and provides career advice for young retina specialists. Intro :15 In this episode :18 About Dr. Pollack :24 The interview :45 Who is Dr. Pollack? 1:10 What’s your favorite part about the field of retina? 2:37 How did you get involved with the ASRS? 3:58 Who write the questions for the PAT survey? 5:54 How should community retina specialists utiliz...
Aug 25, 2020•29 min•Season 1Ep. 1
